lncRNAs: key player in Aβ deposition.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder marked by amyloid-beta (Aβ) plaque accumulation.
• Aβ is generated by secretase enzymes cleaving amyloid precursor protein, leading to neuronal damage via oxidative stress and inflammation.
• Long non-coding RNAs (LncRNAs) are non-protein-coding transcripts involved in gene regulation and neuronal function.

Purpose of the Study:

• To review the mechanisms by which LncRNAs influence Aβ deposition in Alzheimer's disease.
• To classify LncRNAs based on their modes of action in AD pathogenesis.
• To discuss current research challenges and future therapeutic prospects of LncRNAs in AD treatment.

Main Methods:

• Literature review of studies on LncRNAs and Alzheimer's disease.
• Classification of LncRNAs based on their functional pathways affecting Aβ deposition.
• Synthesis of current research findings and identification of knowledge gaps.

Main Results:

• LncRNAs play a significant role in regulating Aβ production and clearance.
• Specific LncRNAs have been identified that modulate pathways involved in Aβ deposition.
• LncRNAs influence AD progression through various mechanisms including gene expression and chromatin remodeling.

Conclusions:

• LncRNAs represent a promising area for understanding and treating Alzheimer's disease.
• Targeting LncRNAs offers potential therapeutic strategies to reduce Aβ burden.
• Further research is needed to fully elucidate LncRNA functions and develop effective AD therapies.